VIVANI MEDICAL INC (VANI) Stock Price, Quote, News and Overview
NASDAQ:VANI - Nasdaq - US92854B1098 - Common Stock - Currency: USD
VANI Quote, Performance and Key Statistics
1.03
-0.01 (-0.96%)
The current stock price of VANI is 1.03 USD. In the past month the price increased by 7.29%. In the past year, price decreased by -43.09%.
VANI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.74 | 229.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 69.61 | 190.61B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.61 | 154.18B | ||
| SYK | STRYKER CORP | 30.44 | 145.56B | ||
| MDT | MEDTRONIC PLC | 15.63 | 107.03B | ||
| BDX | BECTON DICKINSON AND CO | 11.85 | 47.95B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.89 | 44.16B | ||
| IDXX | IDEXX LABORATORIES INC | 41.67 | 38.50B | ||
| RMD | RESMED INC | 26.5 | 35.29B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.08 | 31.76B | ||
| DXCM | DEXCOM INC | 48.65 | 31.47B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.33 | 24.10B |
Related stock screener links
About VANI
Company Profile
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. The company is headquartered in Alameda, California and currently employs 42 full-time employees. The company went IPO on 2014-12-05. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Company Info
VIVANI MEDICAL INC
1350 S. Loop Road
Alameda CALIFORNIA US
Employees: 37
Phone: 14155068462
VIVANI MEDICAL INC / VANI FAQ
What is the stock price of VIVANI MEDICAL INC today?
The current stock price of VANI is 1.03 USD. The price decreased by -0.96% in the last trading session.
What is the ticker symbol for VIVANI MEDICAL INC stock?
The exchange symbol of VIVANI MEDICAL INC is VANI and it is listed on the Nasdaq exchange.
On which exchange is VANI stock listed?
VANI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIVANI MEDICAL INC stock?
9 analysts have analysed VANI and the average price target is 5.1 USD. This implies a price increase of 395.15% is expected in the next year compared to the current price of 1.03. Check the VIVANI MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIVANI MEDICAL INC worth?
VIVANI MEDICAL INC (VANI) has a market capitalization of 61.02M USD. This makes VANI a Micro Cap stock.
How many employees does VIVANI MEDICAL INC have?
VIVANI MEDICAL INC (VANI) currently has 37 employees.
What are the support and resistance levels for VIVANI MEDICAL INC (VANI) stock?
VIVANI MEDICAL INC (VANI) has a support level at 0.96 and a resistance level at 1.05. Check the full technical report for a detailed analysis of VANI support and resistance levels.
Should I buy VIVANI MEDICAL INC (VANI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VANI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VANI, evaluating the profitability, health, valuation and growth aspects
- VIVANI MEDICAL INC (VANI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIVANI MEDICAL INC (VANI) Sales and EPS estimates to see what analysts future expectations are.
- VIVANI MEDICAL INC (VANI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIVANI MEDICAL INC (VANI) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIVANI MEDICAL INC (VANI) Stock Chart to make your own analysis
- VIVANI MEDICAL INC (VANI) Latest news and press-releases to stay up to date.
Does VIVANI MEDICAL INC (VANI) stock pay dividends?
VANI does not pay a dividend.
When does VIVANI MEDICAL INC (VANI) report earnings?
VIVANI MEDICAL INC (VANI) will report earnings on 2025-05-19.
What is the Price/Earnings (PE) ratio of VIVANI MEDICAL INC (VANI)?
VIVANI MEDICAL INC (VANI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
What is the Short Interest ratio of VIVANI MEDICAL INC (VANI) stock?
The outstanding short interest for VIVANI MEDICAL INC (VANI) is 1.16% of its float. Check the ownership tab for more information on the VANI short interest.
VANI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VANI. When comparing the yearly performance of all stocks, VANI is a bad performer in the overall market: 83.39% of all stocks are doing better.
VANI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VANI. The financial health of VANI is average, but there are quite some concerns on its profitability.
VANI Financial Highlights
Over the last trailing twelve months VANI reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 14.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -56.51% | ||
| ROE | -133.37% | ||
| Debt/Equity | 0 |
VANI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to VANI. The Buy consensus is the average rating of analysts ratings from 9 analysts.